10% of all pregnancies are
impacted by hypertension
46% of women with
gestational hypertension will
progress to preeclampsia
Preeclampsia and eclampsia significantly increase the risks of significant maternal and perinatal adverse outcomes. These may include placental abruption, preterm birth, and low birthweight.
Preeclampsia management is focused primarily on maternal hypertension therapy. This can reduce the risk of severe hypertensive episodes and safely prolong gestation.
There is no accepted standard for the management of preeclampsia.
NICaS is designed to assist physicians to determine the exact cause of hypertension for preeclampsia management. NICaS is based on patients’ objective hemodynamic parameters, allowing physicians to reach a deeper understanding of the dynamics concerning each patient’s hypertension and to improve preeclampsia management. With NICaS physicians can now more effectively prescribe the right medication for the right cause of hypertension.
Pregnancy management and preeclampsia diagnosis without guesswork in prescribing medication. NICaS enables personalized treatment suited to the individual hemodynamic profile.
hypertension as a risk
factor that can cause complications during